Our results demonstrated that STI1 treatment significantly decreased apoptosis and cell death in mouse neurons submitted to OGD in a manner that was dependent on PrPC and a7nAChR, but also on the activin A receptor 1 (ALK2), which has emerged as a signaling partner of STI1.